Debayan Ghosh

Biopharmaceuticals, Therapeutic Proteins, Recombinant DNA Technology, Protein Purification, Fermentation, Genomics, Biosimilars.

[Epygen Labs @epygenlabs]

Unleashing the potential of Protein Science for the Energy Industry.

#OilfieldChemistry #Enzyme #EnzymeTechnology #RnD #FilterCakeRemoval #Petrolize #EpygenLabs #Innovation #OilIndustry

@ONGC_ @PDO_OM @ADNOCGroup @aramco @rompetrol

[Epygen Labs @epygenlabs]

An insightful interview with Mr. Debayan Ghosh, Founder & CMD of Epygen Labs, on UAE’s Pearls of Union Channel, highlighting Epygen's journey and its contribution as the first company at Dubai Science Park (@DxbSciencePark) in driving the growth of the region's biotechnology sector.

#EpygenLabs #Biotechnology #DubaiSciencePark #Innovation #LifeSciences #Dubai #IndustrialBiotech #Enzyme #EnzymeEngineering #RecombinantProtein

https://t.co/hejg8heEaP

[Epygen Labs @epygenlabs]

At Epygen, we are advancing biotechnology through sustainable innovation of Enzymes.

As the first company to set up in the Dubai Biotechnology Park, we were recognized for our 20 years of contribution to science and society.

#EpygenLabs #Epygen #Biotechnology #Enzyme

[Kiran Mazumdar-Shaw @kiranshaw]

The story of a life saving medicine called Insulin.

[Debayan Ghosh @DebayanEpygen]

@kiranshaw Indeed a big leap in the history of mankind.

[Debayan Ghosh @DebayanEpygen]

@INSVKaundinya @MinOfCultureGoI @SpokespersonMoD @Indemb_Muscat @sanjeevsanyal @indiannavy @IN_WNC @IN_HQENC @IN_HQSNC Congratulations and 3 cheers for our courageous team🫡🫡🙏🏼🙏🏼

[Debayan Ghosh @DebayanEpygen]

@kiranshaw @YouTube @narendramodi Amazing interview. What can be more inspirational? 🙏🏼🙏🏼

[Debayan Ghosh @DebayanEpygen]

Express Pharma January 2025 @ExpPharma https://t.co/jrqu0i5AUk Biologics CDMO to play key role in India's growth story during Amritkal. Enabling critical healthcare for the world at affordable cost. Thanks @kiranshaw for your kind words. @PMOIndia @DBTIndia @DrJitendraSingh

[Debayan Ghosh @DebayanEpygen]

@DrManikSaha2 Fantastic!

[Debayan Ghosh @DebayanEpygen]

Participated in G20 Science summit Tripura which took strides on Green Renewable Energy. Enzymes play key role. Impeccable arrangements by Tripura Govt showed the state is future ready. @narendramodi @DrManikSaha2 @g20org @S20_India @PrinSciAdvGoI @Ashutos61

[Debayan Ghosh @DebayanEpygen]

@DrManikSaha2 @narendramodi @AmitShah @JPNadda Excellent

[Debayan Ghosh @DebayanEpygen]

@navikakumar @narendramodi Really proud of the work you are doing Navika.

[Debayan Ghosh @DebayanEpygen]

Having worked this hyper-expression platform for decades we know how to make Biologics affordable. Epygen Biotech Announces Funding from India Government for Development of a COVID-19 Vaccine Using Dyadic’s Licensed C1 https://t.co/xJgiisNMa7 via @business

[Debayan Ghosh @DebayanEpygen]

@EpygenBiotech Lots of confusion regarding booster doses of Covid Vaccines in the world.

[Debayan Ghosh @DebayanEpygen]

@IndiaDST @RenuSwarup @DrJitendraSingh @PrinSciAdvGoI @guptaakhilesh63 @PIB_India Congratulations Dr Swarup! DBT and DST are robust pillars of Indian society for the path to progress!

[Debayan Ghosh @DebayanEpygen]

Our partners in developing the most affordable Covid vaccine to discuss how to regain grounds lost to the new mutants including the ones in India! @RenuSwarup @BagaiDr @drharshvardhan @kvijayraghavan @PMOIndia @republic @ETNOWlive #everyindianprotected

[Dyadic Applied BioSolutions @DyadicInc]

Please join us for the Dyadic KOL Fireside Chat featuring a discussion moderated by Dr. David Bramhill with Key Opinion Leaders. A live Q&A session will follow the formal presentations. Register here:https://t.co/PgTMTBuaiG

[Debayan Ghosh @DebayanEpygen]

Dyadic has proven that an affordable Covid vaccine is not a myth, but science! It is rather impossible for conventional hosts to match this vaccine’s outputs through C1-system!
@PMOIndia

@RenuSwarup

@drharshvardhan

@Rupalijee

@republic

@ETNOWlive

[Dyadic Applied BioSolutions @DyadicInc]

Dyadic Advancing Towards Human Clinical Trial of its SARS-CoV-2-S-RBD vaccine candidate, DYAI-100
#healthcare #DYADIC #SARS-CoV-2 #C1

https://t.co/if9SkDPm6W

[Debayan Ghosh @DebayanEpygen]

@RenuSwarup @BIRAC_2012 @drharshvardhan @DBTIndia Congratulations Dr Swarup and team. DBT-BIRAC would surely play a key role in India’s ascend in the millennium! We are proud to be your partners and would look forward to join strides going ahead! @drharshvardhan @kvijayraghavan @PMOIndia

[Debayan Ghosh @DebayanEpygen]

Affordable Covid vaccine is not a myth! It is science! Our collaborators C1 RBD Protein vaccine has proven this. It is rather impossible for other hosts to match this vaccine’s output! @PMOIndia @RenuSwarup @drharshvardhan @Rupalijee @republic @ETNOWlive

[Mark Emalfarb @Emalfarb]

Dyadic Advancing Towards Human Clinical Trial 2 - SARS-CoV-2-S-RBD vaccine candidate DYAI-100 $Dyai
* IIBR reports successful challenge studies using human ACE2 transgenic mice vaccinated with SARS-CoV-2-S-RBD vaccine @DyadicInc @ScottGottliebMD @ASlavitt

https://t.co/DJX05Gxnj8

[Epygen Biotech Pvt. Ltd. @EpygenBiotech]

As per CDC Interim Clinical Considerations for Vaccine use, "vaccination of persons with known current SARS-CoV-2 infection should be deferred until the person has recovered". RT-PCR with nearly 100% accuracy, should be used to test candidates prior to vaccination for safety.